The $30B GenAI Divide Is Coming for Soft Approval Memos

2026-06-22 · Source: Artificial Intelligence on Medium · Field: Business & Management — Corporate Strategy & Leadership, Project & Product Management · Depth: Fundamental Awareness, quick

Summary

MIT NANDA's July 2025 "GenAI Divide: State of AI in Business 2025" report reveals a significant challenge in enterprise Generative AI adoption. The study, based on a review of over 300 public AI initiatives, interviews with 52 organizations, and surveys of 153 senior leaders from January to June 2025, indicates that \$30-40 billion has been invested in GenAI. However, a striking 95% of organizations report no measurable return on investment. Conversely, a mere 5% of integrated pilots are successfully extracting millions in value. The report highlights that many failing pilots lack the ability to remember past work, handle exceptions, or have a single business owner, leading to costs manifesting as backlog, rework, and "renewal theater" rather than clear P&L benefits. This signals an end to "soft approval memos" for GenAI projects.

Key takeaway

For Directors of AI/ML evaluating new Generative AI initiatives, you must shift from "soft approval memos" to rigorous ROI proof gates. The MIT NANDA report indicates 95% of pilots fail to show measurable returns, often due to lacking memory, exception handling, or clear ownership. Ensure your proposals demonstrate direct P&L impact and include robust operational design and a single accountable business owner to secure future funding and avoid costly rework.

Key insights

Most enterprise GenAI investments, totaling \$30-40B, fail to deliver measurable ROI due to operational gaps in memory, exception handling, and ownership.

Principles

• GenAI pilots need measurable P&L impact.
• Operational robustness (memory, exceptions) is critical.
• Single business ownership ensures accountability.

In practice

• Prioritize GenAI projects with clear P&L.
• Build GenAI with robust memory and exception handling.
• Assign single business owners to GenAI initiatives.

Topics

• Generative AI
• Enterprise AI
• ROI Measurement
• AI Governance
• Pilot Programs
• Business Value

Best for: CTO, Investor, VP of Engineering/Data, Executive, Director of AI/ML, Consultant

Related on AIssential

• Applying Generative AI to Business Problems: four priorities for managers and executives — The ease of being impressed by GenAI demos leads to bad investments; focus on production reality.
• Breaking: bad news for three of the biggest IPOs in history — Excessive GenAI usage without clear ROI is unsustainable, leading to significant financial losses for major tech companies.
• Why Your $50M AI Investment Is Burning on Sand ? — AI failures often stem from inadequate data foundations and organizational permission, not just model algorithms.
• OpenAI gets set to go public: can we entrust the financial markets with ChatGPT and AI? — Generative AI's immense operational costs challenge traditional business models, pushing even mission-driven entities towards market-driven financing.
• Active Investors Spent More On Fewer Deals In February — Startup investment is consolidating into fewer, larger deals, particularly in generative AI, despite overall deal count stagnation.
• Salesforce Ventures, Echo Health Ventures back Optura's $17.5M series A to track AI performance - Fierce Healthcare — Quantifying AI's business value is critical, especially in healthcare, where adoption outpaces measurable ROI.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by Artificial Intelligence on Medium.